Hangzhou Neoantigen Therapeutics Co., Ltd.
PrivateCompany Overview
Hangzhou Neoantigen Therapeutics Co., Ltd. is a biotechnology company that develops personalized neoantigen-based cancer immunotherapies, including peptide and mRNA vaccines.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Precision Medicine, Drug Discovery, Medical AI, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Hangzhou Neoantigen Therapeutics Co., Ltd. Comparables
Compare Hangzhou Neoantigen Therapeutics Co., Ltd. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Likang Life Sciences | 87% | |
| Anda Biopharma | 86% | |
| Geneos Therapeutics | 79% | |
Hangzhou Neoantigen Therapeutics Co., Ltd. Funding Rounds
Historical fundraising activity
Hangzhou Neoantigen Therapeutics Co., Ltd. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Hangzhou Neoantigen Therapeutics Co., Ltd.'s valuation, stock price, and market status.